Clinical Trial Update: Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating switching from efavirenz to nevirapine in people with HIV and dyslipidemia, focusing on LDL cholesterol changes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hypercholesterolemia

Drugs mentioned

• EFAVIRENZ (efavirenz)
• NEVIRAPINE (nevirapine)

Snippet

Sponsor: University Hospital, Caen | Conditions: HIV Infections, Hypercholesterolemia | Phase 4 | Status: COMPLETED